Example: Heart Attack

Clinical Trials on Ocular Melanoma

Total 63 results

NCT00168870

Unknown status

Study of Metastatic Ocular Melanoma

Conditions: Ocular Melanoma
NCT01893099

Completed

Sorafenib and Radioembolization With Sir-Spheres® for the Treatment of Metastatic Ocular Melanoma

Conditions: Ocular Melanoma
NCT01200238

Completed

STA-9090(Ganetespib) in Metastatic Ocular Melanoma

Conditions: Ocular Melanoma
NCT00621439

Withdrawn

Investigative Trial of Interferon Alpha-2b To Shrink Cancer of the Eye

Conditions: Ocular Melanoma
NCT03528408

Recruiting

Study of Adjuvant Ipilimumab and Nivolumab in Subjects With High-risk Ocular Melanoma

Conditions: Melanoma; Ocular Melanoma
NCT01814046

Terminated

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Ocular Melanoma

Conditions: Metastatic Ocular Melanoma; Metastatic Uveal Melanoma
NCT01355120

Completed

THE IPI - Trial in Advanced Melanoma: Melanoma Patients With Advanced Disease

Conditions: Ocular Melanoma
NCT01930968

Not yet recruiting

Definity for Ultrasound of Intraocular Tumors

Conditions: Ocular Melanoma
NCT00346372

Terminated

Optical Coherence Tomography of Retinal Abnormalities Associated With Choroidal Nevus, Choroidal Melanoma and Choroidal Melanoma Treated With Iodine-125 Brachytherapy

Conditions: Ocular Melanoma
NCT03172299

Not yet recruiting

Prevention of Neovascular Glaucoma by Intravitreal Injections of Anti-VEGF in Patients Treated With Proton Therapy for a Large Choroidal Melanoma

Conditions: Ocular Melanoma
NCT02909517

Recruiting

The Role of Inflammation in Ocular Tumours

Conditions: Ocular Melanoma
NCT00344799

Recruiting

Cytogenetic Study of Ocular Melanoma

Conditions: Choroidal Melanoma
NCT00351728

Completed

Combined PET/CT Imaging for the Early Detection of Ocular Melanoma Metastasis Compared to CT Scanning Alone

Conditions: Ocular Melanoma; Choroidal Melanoma; Uveal Melanoma
NCT00109005

Completed

Lenalidomide (Revlimid) to Treat Advanced Ocular Melanoma

Conditions: Melanoma
NCT02678572

Active, not recruiting

Percutaneous Hepatic Perfusion in Patients With Hepatic-dominant Ocular Melanoma

Conditions: Melanoma, Ocular
NCT00062933

Completed

A Phase II Study of Isolated Hepatic Perfusion (IHP) in Patients With Ocular Melanoma

Conditions: Melanoma
NCT00421317

Terminated

Imatinib in Adult Patients With Metastatic Ocular Melanoma

Conditions: Melanoma
NCT00489944

Unknown status

Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular Melanoma

Conditions: Intraocular Melanoma
NCT00085306

Completed

Interferon Beta in Treating Patients With Metastatic Cutaneous Melanoma or Ocular Melanoma

Conditions: Stage IV Melanoma; Recurrent Melanoma
NCT01587352

Suspended

Vorinostat in Treating Patients With Metastatic Melanoma of the Eye

Conditions: Ocular Melanoma With Extraocular Extension; Recurrent Uveal Melanoma; Stage IV Uveal Melanoma AJCC v7
NCT01835145

Active, not recruiting

Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed by Surgery

Conditions: Recurrent Uveal Melanoma; Stage III Uveal Melanoma AJCC v7; Stage IIIA Uveal Melanoma AJCC v7; Stage IIIB Uveal Melanoma AJCC v7; Stage IIIC Uveal Melanoma AJCC v7; Stage IV Uveal Melanoma AJCC v7
NCT00020475

Completed

Vaccine Therapy in Treating Patients With Metastatic Melanoma of the Eye

Conditions: Extraocular Extension Melanoma; Recurrent Intraocular Melanoma
NCT00003802

Completed

Pyrazoloacridine in Treating Patients With Metastatic Skin or Eye Melanoma

Conditions: Intraocular Melanoma; Melanoma (Skin)
NCT00482911

Terminated

Lenalidomide, Sunitinib, and Cyclophosphamide in Treating Patients With Stage IV Eye Melanoma

Conditions: Intraocular Melanoma; Malignant Conjunctival Neoplasm
NCT00036816

Terminated

Vaccine Therapy in Treating Patients With Melanoma of the Eye

Conditions: Intraocular Melanoma